Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof
January 23, 2010. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.Patent References 3426011 3816393 Inclusion compound of lankacidin-group antibiotic and use thereof Water soluble cyclodextrin polymers substituted by ionic groups and process for the preparation thereof Inclusion complex of ଲ-cyclodextrin and digoxin Water-soluble mixed ethers of ଲ-cyclodextrin and a process for their preparation Administration of sex hormones in the form of hydrophilic cyclodextrin derivatives Ethers of beta-cyclodextrin and a process for their preparation Pharmaceutical preparations containing cyclodextrin derivatives Partially methylated cyclodextrins and process for producing the same InventorsAssigneeApplicationNo. 469087 filed on 01/23/1990US Classes:514/58, Dextrin or derivative514/778, Starch or derivative514/964, SUSTAINED OR DIFFERENTIAL RELEASE TYPE514/965, Discrete particles in supporting matrix536/103Dextrin or derivativeExaminersPrimary: Griffin, Ronald W.Attorney, Agent or FirmInternational ClassesC08B 037/16A61K 031/71 A61K 031/715 AbstractSulfoalkyl ether cyclodextrin derivatives and their use as solubilizing agents for water insoluble drugs for oral, intranasal, or parenteral administration are disclosed.Other References
|
| ||||||||||||||
